28 Jul 2021 18:10
Ap24
Â
AMENDMENT
FORMÂ 38.5(a)
Â
IRISHÂ TAKEOVERÂ PANEL
Â
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
Â
DEALINGSÂ BYÂ CONNECTEDÂ EXEMPTÂ PRINCIPALÂ TRADERSÂ WITHÂ RECOGNISEDÂ INTERMEDIARYÂ STATUSÂ ANDÂ DEALINGÂ INÂ AÂ CLIENT-SERVINGÂ CAPACITY
Â
1. KEYÂ INFORMATION
Â
Name of exempt principal trader | J.P. Morgan Securities Plc |
Company dealt in | UDG Healthcare Plc |
Class of relevant security to which the dealings being disclosed relate (Note 1) | €0.05 ordinary shares |
Date of dealing | 30 June 2021 |
Â
2. DEALINGS (Note 2)
Â
(a) Purchases and sales
Â
Total number of relevant securities acquired | Highest price paid (Note 3) | Lowest price paid (Note 3) |
1,259,467 | 10.7109 GBP | 10.6900 GBP |
Â
Â
Total number of securities disposed | Highest price received (Note 3) | Lowest price received (Note 3) |
1,254,997 | 10.7150 GBP | 10.6740 GBP |
Â
Â
(b) Derivatives transactions (other than options transactions)
Â
Product name, e.g. CFD | Nature of transaction (Note 4) | Number of relevant securities (Note 5) | Price per unit (Note 3) |
Equity Swap | Decrease Long   Decrease Short         Increase Long      Increase Short      Opening a long position         Opening a short position    | 38  21,463   499  11,763  1,586  19,591  2,539  2,539  863  8,415   224  1,873  497  8,450  45   261,866  200,000  23,000  677,400  376   3,366  135,092  244  451  3,122  1,336  14,273  283   135,074  600  8,234  14,259 | 10.6988 GBP 10.7097 GBP
10.6740 GBP 10.6889 GBP 10.6898 GBP 10.6974 GBP 10.6991 GBP 10.6992 GBP 10.6996 GBP 10.7103 GBP
10.6893 GBP 10.6898 GBP 10.6901 GBP 10.6913 GBP 10.6998 GBP
10.6943 GBP 10.6954 GBP 10.6980 GBP 10.7100 GBP 10.7104 GBP
10.6895 GBP 10.6900 GBP 10.6935 GBP 10.6960 GBP 10.6975 GBP 10.6986 GBP 10.6994 GBP 10.6996 GBP
10.6900 GBP 10.6951 GBP 10.7001 GBP 10.7109 GBP |
Â
Ap25
Â
(c) Options transactions in respect of existing relevant securities
Â
Â
(i) Writing, selling, purchasing or varying
Â
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 5) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 3) |
 |  |  |  |  |  |  |
Â
Â
(ii) Exercising
Â
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 3) |
 |  |  |
Â
Â
3. Â OTHERÂ INFORMATION
Â
Agreements, arrangements or understandings relating to options or derivatives
Â
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
Â
Â
Â
Â
Â
Â
Date of disclosure | 28 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 020 7742 7407 |
Name of offeree/offeror with which connected | UDG Healthcare Plc |
Nature of connection (Note 6) | Financial adviser to CD&R Fund XI |
Â